Literature DB >> 1008588

Hormonal changes in thalassaemia major.

D M Flynn, A Fairney, D Jackson, B E Clayton.   

Abstract

Patients with severe thalassaemia major suffer endocrine and other abnormalities before their eventual death from iron overload due to repeated blood transfusions. The endocrine status of 31 thalassaemic patients aged 2-5 to 23 years was investigated. Exact data were available on the rate and duration of blood transfusion in all of them and in many the liver iron concentration was also known. Although the patients were euthyroid, the mean serum thyroxine level was significantly lower, and the mean thyrotrophic hormone level significantly higher, compared with the values found in normal children. Forty oral glucose tolerance tests with simultaneous insulin levels were performed in 19 children, of whom 5 developed symptomatic diabetes and one had impaired tolerance. Previous tests on all 6 patients were available and some showed raised insulin levels possibly due to insulin resistance. 2 patients had clinical hypoparathyroidism and are described. The parathyroid hormone levels determined by radioimmunoassay in 25 patients were below the mean for the age group in all and outside the reference range in 16. Nonfasting plasma calcium levels were not reduced. Puberty was delayed in some patients. Concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) measured in urine from 7 girls and 5 boys showed considerable variation. In the boys there was an overall tendency for FSH and LH excretion to be low with regard to age, but with respect to puberty rating FSH exretions were normal or low and LH normal or raised. The girls showed a tendency for LH but not FSH excretion to be raised in relation to puberty rating. The severity of the endocrine changes was related to the degree of iron loading and is discussed in relation to previous work in which the iron loading has rarely been accurately indicated nor parathyroid status assessed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008588      PMCID: PMC1546074          DOI: 10.1136/adc.51.11.828

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  [HEMOCHROMATOSIS SECONDARY TO COOLEY'S DISEASE. CLINICAL, BIOLOGICAL AND ANATOMICAL STUDY].

Authors:  J CHAPTAL; R JEAN; A PAGES; H BONNET; R LLORET; J ROUSTAN
Journal:  Pediatrie       Date:  1964-09

2.  TRANSFUSION HEMOCHROMATOSIS IN COOLEY'S ANEMIA.

Authors:  H FINK
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

3.  CARDIAC INVOLVEMENT IN COOLEY'S ANEMIA.

Authors:  M A ENGLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

4.  Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

Authors:  J T ELLIS; I SCHULMAN; C H SMITH
Journal:  Am J Pathol       Date:  1954 Mar-Apr       Impact factor: 4.307

5.  Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man.

Authors:  C D Arnaud; R S Goldsmith; P J Bordier; G W Sizemore
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

Review 6.  Metabolism of parathyroid hormone: physiologic and clinical significance.

Authors:  G V Segre; H D Niall; J F Habener; J T Potts
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

7.  A simple oral test of growth-hormone secretion in children.

Authors:  D Jackson; D B Grant; B E Clayton
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

8.  Growth retardation in thalassemia major.

Authors:  E C Zaino; B Kuo; M S Roginsky
Journal:  Ann N Y Acad Sci       Date:  1969-11-20       Impact factor: 5.691

9.  Measurement of liver-iron concentration in needle-biopsy specimens.

Authors:  M Barry; S Sherlock
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

10.  Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.

Authors:  M Barry; D M Flynn; E A Letsky; R A Risdon
Journal:  Br Med J       Date:  1974-04-06
View more
  21 in total

1.  Thyroid function in major thalassemia patients: Is it related to height and chelation therapy?

Authors:  Peiman Eshragi; Ahmad Tamaddoni; Khadijeh Zarifi; Amir Mohammadhasani; Majid Aminzadeh
Journal:  Caspian J Intern Med       Date:  2011

2.  Effect of hCG or hCG+ treatments in young thalassemic patients with hypogonadotropic hypogonadism.

Authors:  R Balducci; V Toscano; G Finocchi; G Municchi; A Mangiantini; B Boscherini
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

3.  Insulin dependent diabetes in thalassaemia.

Authors:  V De Sanctis; M G Zurlo; E Senesi; C Boffa; L Cavallo; F Di Gregorio
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

Review 4.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

5.  Primary hypothyroidism and the low T3 syndrome in thalassaemia major.

Authors:  A R Sabato; V de Sanctis; G Atti; L Capra; B Bagni; C Vullo
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

6.  Bone growth in thalassaemic children.

Authors:  P Lapatsanis; A Divoli; H Georgaki; S Pantelakis; S Doxiadis
Journal:  Arch Dis Child       Date:  1978-12       Impact factor: 3.791

7.  TSH secretion in thalassemia.

Authors:  I M Spitz; H J Hirsch; H Landau; E Zylber-Haran; V Gross; E A Rachmilewitz
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

8.  Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy.

Authors:  Somchit Jaruratanasirikul; Rarong Chareonmuang; Malai Wongcharnchailert; Vichai Laosombat; Pasuree Sangsupavanich; Kalaya Leetanaporn
Journal:  Eur J Pediatr       Date:  2007-09-25       Impact factor: 3.183

9.  Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.

Authors:  V De Sanctis; M R Gamberini; L Borgatti; G Atti; C Vullo; B Bagni
Journal:  Postgrad Med J       Date:  1985-11       Impact factor: 2.401

10.  The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients.

Authors:  V De Sanctis; G D'Ascola; B Wonke
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.